Despite concerns about the quality of Medicare Advantage encounter data, it’s long past time to make that information available to researchers who want to study the ever-growing privatized Medicare ...

Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, and two colleagues laid out how the agency is working to use real-world data to address the evidence gap between clinical ...

Precision medicine’s got its legion of believers, but there’s a healthy dose of skepticism in the medical community – as outlined in a balanced new JAMA piece, “Precision Medicine: The Future or ...

Two of the biggest medical journals in the world have taken up some big picture mobile health questions this week: How are patients to know which medical apps work out of the sea of available options, ...

While the U.S. healthcare industry has made strides in lowering the number of adverse events, many problems still remain. And one thing could be holding the industry back from achieving the goal of ...

The answer is that the blog post at JAMA received more attention. It’s not surprising, actually. The JAMA piece was in sync with the media; it was about the State of the Union Address, which had ...